* Lilly ups full-year revenue forecast to as much as $92 billion * Weight-loss drugs Mounjaro, Zepbound drive Q3 earnings beat * Medicare pricing fears could ease as Lilly captures new patients (Adds
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Pankaj Vasani, Group CFO of Cube InvIT New Delhi [India], October 29: Cube Highways Trust…
(Corrects one-time in paragraph 2 to 58 cents from 60 cents) By Deena Beasley Oct…
By Nathan Vifflin and Fabrizio La Rocca Oct 29 (Reuters) - STMicroelectronics raised its 2026…
Oct 29 (Reuters) - Cerenome, Inc: * CERENOME COMPLETES ENROLLMENT IN PHASE 2 RESPECT-GBM TRIAL…
VIDEO SHOWS: ENGLAND STRIKER IVAN TONEY ARRIVING AND DEPARTING SOUTHWARK CROWN COURT / EXTERIORS OF…
By Manya Saini Oct 28 (Reuters) - Prediction markets are seeing massive trades for Anthropic…